Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 269

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Open access
Such, E., Cervera, J., Costa, D., Sole, F., Vallespi, T., Luno, E., Collado, R., Calasanz, M. J., Hernandez-Rivas, J. M., Cigudosa, J. C., Nomdedeu, B., Mallo, M., Carbonell, F., Bueno, J., Ardanaz, M. T., Ramos, F., Tormo, M., Sancho-Tello, R., Canizo, C. d., Gomez, V., Marco, V., Xicoy, B., Bonanad, S., Pedro, C., Bernal, T., Sanz, G. F. · 2011 · Haematologica

Abstract

BACKGROUND: The prognostic value of cytogenetic findings in chronic myelomonocytic leukemia is unclear. Our purpose was to evaluate the independent prognostic impact of cytogenetic abnormalities in a large series of patients with chronic myelomonocytic leukemia included in the database of the Spanish Registry of Myelodysplastic Syndromes. DESIGN AND METHODS: We studied 414 patients with chronic myelomonocytic leukemia according to WHO criteria and with a successful conventional cytogenetic analysis at diagnosis. Different patient and disease characteristics were examined by univariate and multivariate methods to establish their relationship with overall survival and evolution to acute myeloid leukemia. RESULTS: Patients with abnormal karyotype (110 patients, 27%) had poorer overall survival (P=0.001) and higher risk of acute myeloid leukemia evolution (P=0.010). Based on outcome analysis, three cytogenetic risk categories were identified: low risk (normal karyotype or loss of Y chromosome as a single anomaly), high risk (presence of trisomy 8 or abnormalities of chromosome 7, or complex karyotype), and intermediate risk (all other abnormalities). Overall survival at five years for patients in the low, intermediate, and high risk cytogenetic categories was 35%, 26%, and 4%, respectively (P<0.001). Multivariate analysis confirmed that this new CMML-specific cytogenetic risk stratification was an independent prognostic variable for overall survival (P=0.001). Additionally, patients belonging to the high-risk cytogenetic category also had a higher risk of acute myeloid leukemia evolution on univariate (P=0.001) but not multivariate analysis. CONCLUSIONS: Cytogenetic findings have a strong prognostic impact in patients with chronic myelomonocytic leukemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2010.030957

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 269

Metadata

Authors
Such, E., Cervera, J., Costa, D., Sole, F., Vallespi, T., Luno, E., Collado, R., Calasanz, M. J., Hernandez-Rivas, J. M., Cigudosa, J. C., Nomdedeu, B., Mallo, M., Carbonell, F., Bueno, J., Ardanaz, M. T., Ramos, F., Tormo, M., Sancho-Tello, R., Canizo, C. D., Gomez, V., Marco, V., Xicoy, B., Bonanad, S., Pedro, C., Bernal, T., & Sanz, G. F.
Venue
Haematologica
Published
2010-11-25
Volume
96
Issue
3
Pages
375-383
ISSN
  • 0390-6078 (ISSN-L)
  • 1592-8721
OpenAlex
W2029679731
Cited by
269
References
19
FWCI
9.52
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytogenetic risk stratification in chronic myelomonocytic leukemia. https://app.cochat.ai/papers/10.3324/haematol.2010.030957
The paper
Such, E., Cervera, J., Costa, D., Sole, F., Vallespi, T., Luno, E., Collado, R., Calasanz, M. J., Hernandez-Rivas, J. M., Cigudosa, J. C., Nomdedeu, B., Mallo, M., Carbonell, F., Bueno, J., Ardanaz, M. T., Ramos, F., Tormo, M., Sancho-Tello, R., Canizo, C. D., . . . Sanz, G. F. (2011). Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica. https://doi.org/10.3324/haematol.2010.030957

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.